Kenya - English - Pharmacy and Poisons Board

sphinx pharmaceuticals ltd 69512-00400 - buprofen b.p - suspension and effervescent granules for oral - ibuprofen b.p 100mg / 5ml - non-steroidal

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ibuprofen 200mg - tablet - 200 mg - active: ibuprofen 200mg excipient: carnauba wax chloroform chloroform spirit   colloidal silicon dioxide diethyl phthalate hypromellose lactose monohydrate magnesium stearate maize starch opadry povidone purified talc sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ibuprofen 400mg - tablet - 400 mg - active: ibuprofen 400mg excipient: carnauba wax chloroform chloroform spirit   colloidal silicon dioxide diethyl phthalate hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry povidone purified talc sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ibuprofen 600mg - tablet - 600 mg - active: ibuprofen 600mg excipient: carnauba wax chloroform chloroform spirit colloidal silicon dioxide diethyl phthalate hypromellose lactose monohydrate magnesium stearate maize starch methanol methylene chloride opadry white y-1-7000 povidone purified talc sodium starch glycolate

Canada - English - Health Canada

merial canada inc - ketoprofen - tablet - 10mg - ketoprofen 10mg - dogs

Canada - English - Health Canada

merial canada inc - ketoprofen - tablet - 5mg - ketoprofen 5mg - cats; dogs

Canada - English - Health Canada

merial canada inc - ketoprofen - tablet - 20mg - ketoprofen 20mg - dogs

Canada - English - Health Canada

merial canada inc - ketoprofen - solution - 10mg - ketoprofen 10mg - cats; dogs

Bangladesh - English - DGDA (Directorate General of Drug Administration)

nipa pharmaceuticals ltd. - ibuprofen - tablet - 400 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

devatis limited - tenoxicam 20mg (+10% overage) - powder for injection - 20 mg - active: tenoxicam 20mg (+10% overage) excipient: ascorbic acid disodium edetate hydrochloric acid mannitol sodium hydroxide trometamol - tenoxicam devatis is indicated in adults for the symptomatic treatment of the following painful inflammatory and degenerative disorders of the musculoskeletal system: - rheumatoid arthritis; - osteoarthritis; - arthrosis; -ankylosing spondylitis; - extra-articular disorders, e.g. tendinitis, bursitis, periarthritis of shoulders (shoulder-hand syndrome) or hips, strains and sprains; - post-operative pain.